Tazarotene is an acetylenic retinoid prodrug of tazarotenic acid (sc-212992) with selective affinity for retinoic acid receptors RARβ and RARγ. Tazarotene also upregulates tazarotene-induced genes (TIGs), including the cell adhesion molecule TIG1 and the tumor-suppressor TIG3.
1. Tang-Liu, D D., et al., 1999. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. Clinical pharmacokinetics. 37(4): 273-87. PMID: 10554045
2. Roeder, A., et al., . Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging. Skin pharmacology and physiology. 17(3): 111-8. PMID: 15087589
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.